ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,356,234 | -61.6% | 34,318 | -60.9% | 0.31% | -80.0% |
| Q3 2022 | $3,531,000 | -4.4% | 87,877 | 0.0% | 1.54% | +72.1% |
| Q2 2022 | $3,694,000 | +7.9% | 87,877 | 0.0% | 0.90% | -20.5% |
| Q1 2022 | $3,424,000 | -2.2% | 87,877 | 0.0% | 1.13% | +60.9% |
| Q4 2021 | $3,502,000 | +6.3% | 87,877 | -3.6% | 0.70% | -39.1% |
| Q3 2021 | $3,295,000 | -11.8% | 91,170 | 0.0% | 1.15% | -6.7% |
| Q2 2021 | $3,737,000 | -8.5% | 91,170 | -2.7% | 1.23% | -15.8% |
| Q1 2021 | $4,086,000 | -13.8% | 93,670 | -1.1% | 1.46% | -13.7% |
| Q4 2020 | $4,738,000 | – | 94,670 | – | 1.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |